StonvexLoading…
StonvexCore line items from YRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | ¥5.72B | ¥5.81B | ¥4.90B |
Operating Income | ¥-5.94B | ¥-4.16B | ¥-2.30B |
Net Income | ¥54.53M | ¥1.58B | ¥2.08B |
EPS (Diluted) | ¥0.31 | ¥9.06 | ¥11.64 |
Total Assets | ¥13.45B | ¥12.98B | ¥10.28B |
Total Liabilities | ¥4.18B | ¥3.44B | ¥2.19B |
Cash & Equivalents | ¥3.35B | ¥3.84B | ¥5.79B |
Free Cash Flow OCF − CapEx | ¥677.88M | ¥1.41B | ¥2.17B |
Shares Outstanding | 174.68M | 172.61M | 174.71M |